The potential danger of anesthetizing a patient on beta-adrenergic blockade therapy has long been recognized. The cases of 73 patients taking propranolol and anesthetized for non-cardiac operations were reviewed with regard to preoperative administration of propranolol and intraoperative and postoperative complications. Of these patients, 72 percent took propranolol to within 24 hours of operation and 85 percent took it to within 48 hours. The mean dose of propranolol was 77 mg/day (range, 10 to 320 mg/day). Anesthetic technics and agents included enflurane, halothane, N2O-narcotic-relaxant, and spinal anesthesia. There were only three episodes of hypotension, all of which responded to a decreased depth of general anesthesia, IV fluid administration, and, in one patient, a small dose of a vasopressor. There were no intraoperative or postoperative deaths. It is concluded that if propranolol is indicated for medical control of the patient's symptoms, it need not be discontinued before surgical anesthesia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1213/00000539-197601000-00001 | DOI Listing |
Pediatr Surg Int
January 2025
Neonatal Intensive Care Unit, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli 8, 00168, Rome, Italy.
Purpose: To compare postoperative outcomes of bedside surgery (BS) with those of surgery performed in the operating room (ORS) in preterm and full-term neonates.
Methods: Data from neonates undergoing major surgical interventions were retrospectively evaluated. Primary outcome was the incidence of postoperative hypothermia.
A A Pract
January 2025
From the Department of Anesthesia, Indiana University School of Medicine, Indianapolis, Indiana.
Interscalene blocks, commonly used for shoulder surgery analgesia, often cause transient phrenic nerve palsy, leading to hemi-diaphragmatic paresis. This complication is particularly problematic in patients with pulmonary comorbidities and has been extensively investigated. However, its impact on patients with Fontan physiology remains less understood with limited representation in the literature.
View Article and Find Full Text PDFA A Pract
January 2025
From the Department of Anesthesia and Perioperative Medicine, Medical University of South Carolina, Charleston, South Carolina.
We report a case of a parturient with severe cardiac disease requiring elective termination of pregnancy. The patient underwent successfully monitored anesthesia care using remimazolam for dilation and curettage. The patient remained hemodynamically stable and appropriately sedated while achieving optimal procedural conditions.
View Article and Find Full Text PDFActa Anaesthesiol Scand
February 2025
Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Background: Intravenous albumin is used for resuscitation and substitution but is not supported by high-certainty evidence. As clinical practice likely varies, we aimed to describe the issuing of albumin solutions across Danish public hospitals.
Methods: We assessed issuing of intravenous albumin solutions (5% and 20%) to all Danish public hospitals in 2022.
Curr Opin Clin Nutr Metab Care
December 2024
Pain Management and Palliative Care, Department of Anesthesia, Intensive Care and Emergency, Molinette Hospital, University of Turin, Turin, Italy.
Purpose Of Review: Several types of injectable lipid emulsions (ILEs) have become available for parenteral nutrition. The purpose of this review is to highlight the most recent and interesting articles in the field of ILEs.
Recent Findings: Recent literature has compared ILEs in various clinical scenarios (e.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!